Amid all the anecdotes and discussions around our numerous options for minimally invasive glaucoma surgery, hard data have the unique power to cut through the noise.
That is certainly true with one of our long-standing treatment options, endoscopic cyclophotocoagulation (ECP). Initially, some surgeons approached ECP more aggressively, which caused inflammatory challenges and complications that meant this option was not truly “minimally invasive.” With overtreatment, postoperative inflammation was significant, and many surgeons opted not to utilize ECP in their surgical